| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,887 |
8,026 |
$2.98M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,005 |
10,637 |
$2.54M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
15,994 |
13,437 |
$2.15M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
15,867 |
14,380 |
$1.96M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
11,099 |
9,184 |
$1.95M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
57,203 |
50,465 |
$1.88M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
6,680 |
5,799 |
$1.78M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
39,336 |
35,596 |
$1.26M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
39,361 |
35,532 |
$1.26M |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
8,137 |
6,605 |
$900K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
28,469 |
25,141 |
$869K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
5,131 |
4,347 |
$708K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
21,918 |
19,417 |
$629K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
3,374 |
3,049 |
$592K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
934 |
674 |
$564K |
| 59025 |
Fetal non-stress test |
4,009 |
3,204 |
$529K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
24,571 |
22,282 |
$515K |
| 80081 |
|
5,569 |
5,096 |
$374K |
| 19318 |
|
704 |
578 |
$346K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
14,531 |
13,083 |
$299K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
48,244 |
39,777 |
$299K |
| 76830 |
Ultrasound, transvaginal |
1,299 |
1,229 |
$259K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
8,879 |
7,840 |
$258K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
438 |
313 |
$248K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
7,310 |
6,524 |
$221K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,432 |
4,064 |
$215K |
| 81025 |
|
30,064 |
26,471 |
$189K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,454 |
1,365 |
$146K |
| 80306 |
|
9,468 |
8,476 |
$141K |
| 76857 |
|
1,263 |
1,157 |
$138K |
| 86703 |
|
11,731 |
10,932 |
$123K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
17,992 |
16,014 |
$118K |
| 87653 |
|
3,417 |
3,213 |
$116K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
236 |
204 |
$115K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
826 |
445 |
$103K |
| 80053 |
Comprehensive metabolic panel |
12,131 |
9,400 |
$98K |
| 84702 |
|
7,558 |
6,320 |
$97K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,473 |
3,036 |
$86K |
| 77066 |
Tomosynthesis, mammo |
825 |
711 |
$77K |
| 87660 |
|
4,834 |
3,793 |
$77K |
| 87480 |
|
4,580 |
3,586 |
$74K |
| 87510 |
|
4,582 |
3,586 |
$73K |
| 76642 |
|
522 |
492 |
$69K |
| 86592 |
|
16,202 |
15,088 |
$66K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,035 |
881 |
$64K |
| 81000 |
|
20,702 |
18,155 |
$62K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,069 |
1,805 |
$58K |
| 80055 |
|
2,612 |
2,365 |
$51K |
| 90715 |
|
1,911 |
1,744 |
$50K |
| 76801 |
|
311 |
302 |
$46K |
| T2101 |
Human breast milk processing, storage and distribution only |
2,287 |
31 |
$39K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,209 |
1,651 |
$38K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
401 |
206 |
$35K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,048 |
3,357 |
$33K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,421 |
1,332 |
$33K |
| 86803 |
|
2,233 |
1,937 |
$26K |
| 82950 |
|
5,834 |
5,514 |
$26K |
| 87210 |
|
6,666 |
5,899 |
$25K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
507 |
457 |
$25K |
| 85660 |
|
4,800 |
4,270 |
$23K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,848 |
2,496 |
$23K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
451 |
406 |
$21K |
| 81002 |
|
7,504 |
5,687 |
$18K |
| 86300 |
|
923 |
824 |
$16K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,245 |
1,402 |
$14K |
| 82378 |
|
880 |
784 |
$14K |
| 76820 |
|
118 |
90 |
$14K |
| 82951 |
|
1,065 |
1,005 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
856 |
758 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
219 |
178 |
$12K |
| 87340 |
|
1,104 |
1,014 |
$11K |
| 87070 |
|
1,500 |
1,289 |
$11K |
| 90686 |
|
706 |
670 |
$10K |
| 77062 |
|
563 |
468 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
2,959 |
2,379 |
$9K |
| 82947 |
|
1,928 |
1,748 |
$8K |
| 90651 |
|
36 |
36 |
$7K |
| 83615 |
|
1,336 |
1,160 |
$7K |
| J3490 |
Unclassified drugs |
3,398 |
677 |
$6K |
| 87205 |
|
1,613 |
1,437 |
$6K |
| 82677 |
|
265 |
252 |
$6K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
14 |
14 |
$6K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
42 |
40 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,158 |
1,041 |
$6K |
| 81001 |
|
2,293 |
2,089 |
$6K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
56 |
27 |
$5K |
| 81003 |
|
4,628 |
3,853 |
$5K |
| G0378 |
Hospital observation service, per hour |
16 |
12 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
330 |
221 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
48 |
48 |
$4K |
| 82105 |
|
278 |
264 |
$4K |
| 86336 |
|
278 |
264 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
234 |
160 |
$4K |
| 85044 |
|
980 |
899 |
$4K |
| 96417 |
|
51 |
39 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
158 |
129 |
$3K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
162 |
137 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
261 |
194 |
$3K |
| 80061 |
Lipid panel |
249 |
214 |
$3K |
| 86850 |
|
1,512 |
1,021 |
$3K |
| 82962 |
|
675 |
541 |
$2K |
| 86780 |
|
234 |
202 |
$2K |
| V5266 |
Battery for use in hearing device |
328 |
188 |
$2K |
| 86704 |
|
193 |
167 |
$2K |
| 84460 |
|
484 |
403 |
$2K |
| 84450 |
|
484 |
403 |
$2K |
| 84439 |
|
230 |
215 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,134 |
883 |
$2K |
| 82565 |
|
431 |
360 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
26 |
24 |
$2K |
| 86706 |
|
167 |
154 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
1,466 |
1,004 |
$2K |
| 84550 |
|
470 |
387 |
$2K |
| 84146 |
|
92 |
87 |
$2K |
| 86900 |
|
1,743 |
1,194 |
$2K |
| 86901 |
|
1,684 |
1,152 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
589 |
431 |
$1K |
| 99385 |
|
101 |
63 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
456 |
38 |
$1K |
| 84520 |
|
446 |
360 |
$1K |
| 81005 |
|
797 |
608 |
$1K |
| 99215 |
Prolong outpt/office vis |
24 |
22 |
$1K |
| 82570 |
|
330 |
278 |
$1K |
| 71045 |
Radiologic examination, chest; single view |
12 |
12 |
$1K |
| 90656 |
|
122 |
110 |
$1K |
| 94762 |
|
191 |
125 |
$991.65 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
26 |
26 |
$857.90 |
| 84156 |
|
346 |
291 |
$803.65 |
| 00402 |
|
396 |
339 |
$780.84 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,297 |
1,049 |
$747.17 |
| V5264 |
Ear mold/insert, not disposable, any type |
23 |
13 |
$521.97 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
13 |
12 |
$473.05 |
| 85027 |
|
375 |
329 |
$463.29 |
| 88142 |
|
58 |
34 |
$402.87 |
| 86304 |
|
34 |
25 |
$378.74 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
12 |
$335.09 |
| 0002A |
|
17 |
14 |
$293.37 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
17 |
14 |
$259.72 |
| 83690 |
|
44 |
39 |
$256.29 |
| 86705 |
|
16 |
16 |
$213.15 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
48 |
39 |
$178.08 |
| 84134 |
|
27 |
25 |
$166.32 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
152 |
131 |
$164.87 |
| 0001A |
|
18 |
18 |
$160.00 |
| 82607 |
|
19 |
12 |
$146.40 |
| 82746 |
|
19 |
12 |
$142.76 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
62 |
29 |
$141.45 |
| 82952 |
|
37 |
36 |
$137.20 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
56 |
50 |
$114.92 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
150 |
110 |
$114.40 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
779 |
403 |
$78.09 |
| 82248 |
|
13 |
13 |
$58.08 |
| 82247 |
|
13 |
13 |
$58.08 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
628 |
480 |
$53.85 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
15 |
14 |
$49.38 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
184 |
121 |
$47.46 |
| A6223 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing |
557 |
471 |
$40.61 |
| A4600 |
Sleeve for intermittent limb compression device, replacement only, each |
79 |
52 |
$32.81 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
39 |
28 |
$26.62 |
| A9150 |
Non-prescription drugs |
135 |
112 |
$24.71 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
136 |
86 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
13 |
12 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
16 |
12 |
$0.00 |
| 91300 |
|
37 |
32 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
136 |
98 |
$0.00 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
49 |
42 |
$0.00 |
| 94770 |
|
26 |
13 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
28 |
26 |
$0.00 |
| 00400 |
|
15 |
12 |
$0.00 |